Tumor cells were negative for clear cell type RCC markers, CD10 and vimentin, and positive for chromophobe cell type RCC markers, E-cadherin and CK7, as well as oncocytic cell markers, CK8 and CK18 (Fig. 6). This evidence concerns the gene KRT7 and renal cell carcinoma.